A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)

NCT01655992 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

386

Enrollment

OTHER

Sponsor class

Stopped The sponsor decided to stop the study.

Conditions

Metastatic Breast Cancer

Interventions

DRUG: capecitabine
DRUG: S1 generic

Sponsor

Fudan University